Vertex obtains receives European approval for cystic fibrosis oral medicine
The European Commission has approved Vertex Pharmaceuticals' oral medicine Kalydeco (ivacaftor) for people with cystic fibrosis (CF).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news
More News: Cystic Fibrosis | Pharmaceuticals